Your browser doesn't support javascript.
loading
Evaluation of Cognitive Functions in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Prospective Pilot Study.
Baran, Gozde; Yildiz, Suleyman Sezai; Oner, Ozge Gonul; Gurdal, Ahmet; Keskin, Kudret; Sigirci, Serhat; Orta Kilickesmez, Kadriye; Babacan Yildiz, Gulsen.
Affiliation
  • Baran G; Department of Neurology, Sancaktepe Sehit Prof. Dr. Ilhan Varank Research and Training Hospital, 34785 Istanbul, Turkey.
  • Yildiz SS; Department of Cardiology, University of Health Sciences, SBÜ Prof. Dr. Cemil Tascioglu City Hospital, 34384 Istanbul, Turkey.
  • Oner OG; Department of Neurology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, 34722 Istanbul, Turkey.
  • Gurdal A; Department of Cardiology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, 34396 Istanbul, Turkey.
  • Keskin K; Department of Cardiology, University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, 34396 Istanbul, Turkey.
  • Sigirci S; Private Consultant, 34365 Istanbul, Turkey.
  • Orta Kilickesmez K; Department of Cardiology, Liv Hospital, 34340 Istanbul, Turkey.
  • Babacan Yildiz G; Department of Neurology, Istanbul Research and Training Hospital, 34098 Istanbul, Turkey.
Diagnostics (Basel) ; 14(14)2024 Jul 11.
Article in En | MEDLINE | ID: mdl-39061629
ABSTRACT

PURPOSE:

It is not clear whether cognitive functions are impaired in young patients with acute coronary syndrome (ACS). This study aims to detect whether or not there is cognitive impairment and cerebral changes in young patients with ACS undergoing percutaneous coronary intervention (PCI). PATIENTS AND

METHODS:

All 50 patients with ACS who were treated with primary PCI were eligible for this prospective study. All participants had normal cognitive function before ACS. Brain magnetic resonance imaging (MRI) was performed to quantify changes in brain white and gray matter. Cognitive functions (CFs) were evaluated by seven cognitive tests. Patients were categorized by MRI findings and test scores were compared from the first day to after the first month.

RESULTS:

We determined 25 patients with impaired CFs on the first day. After the first month, we identified 18 patients with transient impaired CFs. No structural difference was observed between impaired CF and normal CF. While 25 patients had a score of 1 according to Fazekas, 10 patients had a score of 1 according to MTLA. While the mean Stroop test completion time and Stroop test error rate scores were significantly higher on the first day than after the first month in the Fazekas+ group (p = 0.003, p < 0.001, respectively), other cognitive test scores-except clock drawing test, digital span forwards, and backwards-were significantly lower on the first day compared to after the first month in the Fazekas+ group (p < 0.05).

CONCLUSIONS:

Patients with ACS have transient impairment in cognitive functions. Acute coronary syndrome is not associated with structural changes in the brain.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Diagnostics (Basel) Year: 2024 Type: Article Affiliation country: Turkey

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Diagnostics (Basel) Year: 2024 Type: Article Affiliation country: Turkey